From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Says Raised $38M Last Year, Highlights $118M Cash On Balance Sheet; Says No Principle Repayment For 4 Years On $125M Convertible Debt